Abbonarsi

OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY TECHNOLOGY - 09/09/11

Doi : 10.1016/S0891-5520(05)70025-8 
Nancy J. Mortlock, CRNI a, Thomas Schleis, CRNI b
a Infectious Diseases Northwest, PS; Sacred Heart Medical Center; Deaconess Medical Center; and Valley General Medical Center, Spokane (NJM) 
b Pharmacy Services, Northwest Medical Specialties, PLLC, Tacoma, (TS), Washington 

Riassunto

Health care costs are continuing to spiral upward despite government and public insistence on cost containment. To meet the challenge, medical professionals and organizations are seeking opportunities for cost reduction and alternatives for delivery of health care. One of these alternatives, providing intravenous antimicrobial infusion therapy in an ambulatory infusion center or the patient's home, commonly known as outpatient parenteral antimicrobial therapy (OPAT), has gained popularity and has been an effective alternative to hospitalization.19 Today, patients are discharged sooner, or hospitalization is avoided altogether, reducing the overall cost of providing therapy. This is not without some limitations, however, because outpatient infusion therapy can require the use of sophisticated venous access devices and medication delivery systems. It also requires the expertise of medical professionals trained in the delivery of care with this model—a model that is quite different from other health care delivery systems such as the hospital setting. The patient also needs to become an integral member of the health care team and be responsible for a great deal of the therapy to ensure the effectiveness of this model.

Tools that allow the effective delivery of care using the OPAT model are proper venous access and medication delivery systems. Unlike the earliest venous access methods and infusion devices that consisted of quills for needles and animal bladders for medication reservoirs, today's venous catheter systems and infusion devices are much more sophisticated, versatile, and certainly sterile. Because of technologic advancements in both venous access devices and medication delivery systems, it is now easier to provide safe intravenous infusion therapy in the outpatient setting. Improvements in vascular access devices have resulted in soft, flexible, hypoallergenic materials of varied lengths and internal lumen diameters or gauges.6, 15, 32 Multiple-lumen catheters are also available, allowing the concurrent infusion of medications that cannot be premixed. These devices can remain in place for extended periods of time without infection, providing safe and reliable venous access.23, 30 Advances in medication delivery systems allow complex or multiple therapies to be provided with little effort by the patient and have made outpatient therapy available to a wider range of patients.37 Where currently available infusion devices excel is in their ability to perform multiple and complex functions while being relatively simple to operate for clinicians and patients.

Patient selection is a very important criterion when considering OPAT, and not all patients are suitable candidates.8 Providing intravenous therapy outside of the hospital requires that patients be carefully chosen, properly trained in aseptic technique, and educated about potential venous access, infusion device, and medication complications. Although this may be time consuming up front, the payoff is a more cost-effective delivery system that most patients prefer over hospitalization.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Nancy J. Mortlock, CRNI, Infectious Diseases Northwest, 105 W. 8th Avenue, Suite 350, Spokane, WA 99204


© 1998  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.© 1997  © 1993  © 1997  © 1997 
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 12 - N° 4

P. 861-878 - dicembre 1998 Ritorno al numero
Articolo precedente Articolo precedente
  • PHARMACOKINETICS AND PHARMACODYNAMICS OF OUTPATIENT INTRAVENOUS ANTIMICROBIAL THERAPY
  • David Andes, William A. Craig
| Articolo seguente Articolo seguente
  • OUTPATIENT INTRAVENOUS ANTIBIOTIC THERAPY FOR ENDOCARDITIS
  • Susan J. Rehm

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.